Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Azathioprine and 6-Mercaptopurine: A Meta-analysis
David Kotlyar(National Institutes of Health), Gary R. Lichtenstein(Hospital of the University of Pennsylvania), Ann Tierney(University of Pennsylvania), Colleen Brensinger(University of Pennsylvania), Wojciech Błoński(Binghamton University), Laurent Beaugerie(Sorbonne Université), James D. Lewis(University of Pennsylvania), Laurent Peyrin‐Biroulet(Inserm), María Chaparro(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Edward V. Loftus(Mayo Clinic), Meenakshi Bewtra(University of Pennsylvania), Florian Beigel(Ludwig-Maximilians-Universität München), Livia Biancone(University of Rome Tor Vergata), Manuel Van Domselaar(Hospital Universitario Ramón y Cajal), Sandipani Sandilya(Montefiore Medical Center), Javier P. Gisbert(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas)
Cited by 405
Related Papers
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
|Science|2011|6.6k
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
|Nature Medicine|2013|4.4k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Management of <i>Helicobacter pylori</i> infection—the Maastricht IV/ Florence Consensus Report
|Gut|2012|2.3k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k